Neurological Manifestations of Mycoplasma pneumoniae Infection in Hospitalized Adults During the 2023–2024 French Epidemic, Clinical Characterization and Comparative Outcomes: A Multicenter Study
Open Forum Infectious Diseases · 01.07.2026 · 13 (7)
DOI: 10.1093/ofid/ofag406 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 06.07.2026. Verfasst von Matthieu Holub und 26 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Service de Maladies Infectieuses, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié Salpetrière, Pierre Louis Institu…. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Mycoplasma pneumoniae (MP) primarily causes respiratory infections but can lead to neurological manifestations. This study aimed to characterize these manifestations in adults during an epidemic.
Methods
The national MYCADO cohort included 1309 adults hospitalized with MP infection during the 2023–2024 French epidemic. An ancillary study identified and described MP-related central (CNS) and peripheral (PNS) nervous system manifestations. Data were retrospectively extracted from medical records, with clinical follow-up up to 3 months after discharge.
Results
Twenty-eight patients with neurological manifestations attributable to MP were identified (2.1% of the cohort). Of these, 19 affected the CNS, including encephalitis (n = 8), myelitis (n = 3), encephalo-myelitis (n = 2), isolated meningitis (n = 6), and cerebral vasculitis (n = 1). Nine involved the PNS: Guillain-Barré syndrome (n = 6), peripheral polyneuropathy (n = 2), and multifocal neuropathy (n = 1). The median age (interquartile range) was 35 years (29–49) years; 60.7% were men. Neurological symptoms appeared a median of 7 days after MP infection onset. Nearly half (46.4%, n = 13) required intensive care; neurological failure was the leading cause of intensive care unit transfer (12/13, 92.3%). Compared with MP patients without neurological manifestations, those with neurological involvement had longer hospital stays (13 vs 9 days; P < .001), more frequent invasive mechanical ventilation (35.7% vs 4.2%; P < .001), and more rehabilitation transfers (42.8% vs 4.3%; P < .001). At discharge, neurological sequelae were present in 47.3% of CNS patients and all Guillain-Barré syndrome (GBS) patients. At 3 months, sequelae persisted in 36.8% of CNS patients and all GBS patients.
Conclusions
In adults, MP infection causes rare but diverse and frequently severe neurological manifestations that worsen clinical course and result in long-term disability.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sorbonne Université, Service de Maladies Infectieuses, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié Salpetrière, Pierre Louis Institute of Epidemiology and Public Health (iPLESP), INSERM U1136, Paris, Fr…
- Service de Neurologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié Salpetrière, Paris, France.
- Service de Maladies Infectieuses, Assistance Publique-Hôpitaux de Paris (AP-HP), CHU Bichat, Paris, France.
- Service de Maladies Infectieuses, CHRU Nancy, Nancy, France.
- Service de Maladies Infectieuses et Tropicales, CHU Poitiers, Poitiers, France.
- Service de Maladies Infectieuses, CHU Besançon, Besançon, France.
ORCID-Profile: Matthieu Holub, Céline Louapre, Alexandre Bleibtreu, Victor Gerber, Yannick Fedun, Natacha Mrozek, Marion Le Marechal, Valérie Pourcher, Romain Palich
Zitieren
APA
Holub, M., Gavaud, A., Louapre, C., Bleibtreu, A., Mailhe, M., Goehringer, F., Le Moal, G., Bohard, L., Lecompte, A. S., Avenel, M., Wemmert, C., Luque Paz, D., Gerber, V., Dureault, A., Fedun, Y., Girardie, P., Mrozek, N., Leautez-Nainville, S., Pourbaix, A., …, & MYCADO Study Group (2026). Neurological Manifestations of Mycoplasma pneumoniae Infection in Hospitalized Adults During the 2023–2024 French Epidemic, Clinical Characterization and Comparative Outcomes: A Multicenter Study. Open Forum Infectious Diseases, 13(7). https://doi.org/10.1093/ofid/ofag406
Vancouver
Holub M, Gavaud A, Louapre C, Bleibtreu A, Mailhe M, Goehringer F, et al. Neurological Manifestations of Mycoplasma pneumoniae Infection in Hospitalized Adults During the 2023–2024 French Epidemic, Clinical Characterization and Comparative Outcomes: A Multicenter Study. Open Forum Infectious Diseases. 2026;13(7). doi:10.1093/ofid/ofag406
BibTeX
@article{Holub2026,
author = {Holub, Matthieu and Gavaud, Ariane and Louapre, Céline and Bleibtreu, Alexandre and Mailhe, Morgane and Goehringer, Francois and Le Moal, Gwenael and Bohard, Louis and Lecompte, Anne Sophie and Avenel, Marine and Wemmert, Charlotte and Luque Paz, David and Gerber, Victor and Dureault, Amélie and Fedun, Yannick and Girardie, Pierre and Mrozek, Natacha and Leautez-Nainville, Sophie and Pourbaix, Annabelle and Le Marechal, Marion and Lebeaux, David and Cazanave, Charles and Pourcher, Valérie and Martin-Blondel, Guillaume and Palich, Romain and MYCADO Study Group, MYCADO Study Group and MYCADO Study Group, MYCADO Study Group},
title = {Neurological Manifestations of Mycoplasma pneumoniae Infection in Hospitalized Adults During the 2023–2024 French Epidemic, Clinical Characterization and Comparative Outcomes: A Multicenter Study},
journal = {Open Forum Infectious Diseases},
year = {2026},
volume = {13},
number = {7},
doi = {10.1093/ofid/ofag406}
}
EUVIMED